Clinical Trials Directory

Trials / Completed

CompletedNCT06755892

The Effect of 16-week Dietary Intake of Food Supplements Containing Collagen and MSM on Skin

The Effect of 16-week Dietary Intake of Food Supplements Containing Collagen on Dermis Density and Other Skin Parameters: Double Blind, Placebo-controlled, Randomised Five-way Study Comparing the Efficacy of Four Test Products

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
139 (actual)
Sponsor
VIST - Faculty of Applied Sciences · Academic / Other
Sex
Female
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to compare the effects of multiple-dose 16 weeks daily dietary supplementation with 5 g or 3 g of collagen in combination with 1 g or 1.5 g of MSM and 80 mg vitamin C (see 1.2. Investigational and placebo product profile) on skin in healthy human subjects in comparison to placebo product. The main objective is to show that test products have beneficial effects on dermis density, and also on other skin parameters and to investigate differences in the effects among test products.

Detailed description

Single centre, randomized, double-blind, placebo-controlled, one-period effectiveness study will include 135 subjects. Subjects will be divided in five groups, 27 in each. Test group 1 (IP1 group) will receive investigational product 1 (IP1, daily dose 25 mL: collagen 5 g, MSM: 1,0 g, vitamin C: 80 mg), test group 2 (IP2 group) will receive investigational product 2 (IP2, daily dose 25 mL: collagen 3 g, MSM: 1,5 g, vitamin C: 80 mg), test group 3 (IP3 group) will receive investigational product 3 (IP3, daily dose 25 mL: collagen 3 g, MSM: 1,0 g, vitamin C: 80 mg), test group 4 (IP4 group will receive investigational product 4 (IP4, daily dose 25 mL: collagen 3 g, vitamin C: 80 mg) and the placebo group will receive placebo product without those active ingredients (25 mL: 0 g collagen, 0 g MSM). Participants will test continuous administration of placebo or investigational products for 16 weeks to demonstrate and assess multiple-dose effects.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTColMSM-HLParticipants will test continuous administration of investigational product for 16 weeks.
DIETARY_SUPPLEMENTPlacebo syrupParticipants will test continuous administration of placebo product for 16 weeks.
DIETARY_SUPPLEMENTColMSM-LHParticipants will test continuous administration of investigational product for 16 weeks.
DIETARY_SUPPLEMENTColMSM-LLParticipants will test continuous administration of investigational product for 16 weeks.
DIETARY_SUPPLEMENTCol-LParticipants will test continuous administration of investigational product for 16 weeks.

Timeline

Start date
2025-01-27
Primary completion
2025-06-17
Completion
2025-06-17
First posted
2025-01-01
Last updated
2025-10-02

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT06755892. Inclusion in this directory is not an endorsement.